Boston Scientific (BSX) PT Raised to $130 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $45.69 -0.7%
Rating Summary:
31 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
31 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
Morgan Stanley analyst Patrick Wood raised the price target on Boston Scientific (NYSE: BSX) to $130.00 (from $125.00) while maintaining a Overweight rating.
You May Also Be Interested In
- TD Cowen on Boston Scientific (BSX): 'Cyberattack To Weigh on Q3 Results; We Remain Bullish on the Setup for 2027'
- Edwards Lifesciences faces stock risk ahead of trial results says Stifel
- Cheesecake Factory (CAKE) PT Raised to $80 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
